Chris Bunka, Chairman and CEO, Lexaria Bioscience Corp.
Chris Bunka is Chairman of the Board and CEO of Lexaria Bioscience and previously a serial entrepreneur for three decades. He has been instrumental in the success of several private and public companies since the early 1990’s and has extensive experience in the capital markets, project acquisition and corporate finance. He is also a recognized inventor on many of Lexaria’s existing and pending patents. A published author and accomplished public speaker, he has been invited to speak on investment strategies across North America and Europe and has appeared on TV, radio and in print.